LEADER 01295nas  22004693  450 
001 9910555176803321
005 20240810213015.0
011   $a2642-3561
035   $a(DE-599)ZDB3009875-0
035   $a(OCoLC)1090238939
035   $a(CKB)4100000008103969
035   $a(CONSER)--2019200189
035   $a(EXLCZ)994100000008103969
100   $a20190320a20209999  ---         a
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aLiver cancer international
210 31$aHoboken, NJ  :$cJohn Wiley & Sons Inc.,$d[2020]-
300   $aRefereed/Peer-reviewed
517 1 $aLCI
531 0 $aLiver cancer int.
606   $aLiver$xCancer$vPeriodicals
606   $aLiver Neoplasms
606   $aMedical Oncology
606   $aNeoplasms
606   $aLiver$xCancer$2fast$3(OCoLC)fst01000624
606   $aFoie$xCancer$vPériodiques
608   $aPeriodicals.$2fast
615  0$aLiver$xCancer
615 12$aLiver Neoplasms
615 12$aMedical Oncology
615 12$aNeoplasms
615  7$aLiver$xCancer.
615  6$aFoie$xCancer
676   $a616.99436
906   $aJOURNAL
912   $a9910555176803321
996   $aLiver cancer international$92817396
997   $aUNINA